Chris is Head of Program Management at his second biotech start-up.  Chris joined FRG as a Strategic Advisor for the Life Sciences sector with broad expertise in Biopharm Operations and Quality Management. In his third decade in the Life Science industry, Chris cultivated a user perspective intersecting R&D, Tech Transfer, and Sterile Manufacturing with both Reusable and Single-use technologies, suite Startups, Validations, and Shipping with Quality Management, including FDA Consent Decree Remediation, and Third-Party Oversight.  Chris led Program and Alliance Management for international programs valued over $100M, where he led highly technical, global teams assuring the Product, Process, Quality, and Business parameters of a first-of-its-kind cell therapy Drug Product. Chris’ has a keen vision to architect near-term solutions while simultaneously scouting a path for long-term success, leading his teams to be right-first-time and cost-effective in bringing products to market that protect health. 

Chris is a Certified Manager of Quality and Organizational Effectiveness and holds a BS in Biology from Truman State University.